Back to Funding Main Page
The Singapore-China Joint Research Programme (JRP) was signed in 1998 to stimulate cooperative research as well as to advance science and technology in both countries. As part of this agreement, the Agency for Science, Technology and Research, Biomedical Research Council (A*STAR BMRC) and the Ministry of Science and Technology (MOST), People's Republic of China held 9 previous grant calls. The first 8 calls were focused on the fields of Physical & Engineering Sciences and the 9th Joint Grant Call was the first call centred on Biomedical Sciences, in the area of Cancer Sciences. A*STAR BMRC and MOST are pleased to announce the launch of the 10th Call for Proposals under the Singapore - China JRP in the area of "Metabolism and Obesity", an area of increased prevalence in both countries and worldwide. The 10th Joint Grant Call aims to support bilateral research collaborations in the field of metabolism and obesity to advance our understanding of the biological mechanisms that regulate metabolism and how they are dysregulated in obesity. The aim is to translate basic scientific knowledge into improved diagnosis, treatment and prevention of Obesity and Metabolism related diseases.
This grant call will give preference to projects involving one or more of the following aspects:
a) In the following Sub-research areas
• Molecular mechanisms of energy homeostasis regulation
• Mechanism of inflammation in obesity
• Clinical prevention and treatment studies in obesity complications (e.g. Obstructive sleep apnea & cardiovascular disease)
b) Involving one or more of the following aspects:
• Innovative approaches
• Bench to Bedside and Bedside to Bench Translational Research
• Multidisciplinary science and multi-institutional
The maximum funding quantum for each project (for Singapore Grantee):
||3 years |
MOST would fund ~RMB$1.5M for the China Grantee.
1. This call is open to Singapore public sector research organisations, including A*STAR RIs.
2. For every proposal submitted, there should be 2 Principal Investigators (one Singapore-based, and one China-based). MOST will fund the China grantee up to RMB 1mil.
3. The China-based PI must concurrently submit the joint proposal to China's MOST.
4. Proposals must not be duplicative or substantially similar to any previous project or proposal submission in the 8th JRP.
5. No individual should be represented in more than two proposals.
6. Proprietary or confidential information must be clearly indicated in the proposal.
The proposals would be assessed based on:
Project has to address an important problem or a critical barrier to progress in the field. The success of the project should improve scientific knowledge, technical capability, and/or clinical practice, and aim to change the concepts, methods, technologies, treatments or preventative interventions in cancer sciences.
The collaborative project should seek to shift current research or clinical practice paradigms by utilizing novel (or a refinement / improvement of) theoretical concepts, approaches or methodologies, instrumentation, or interventions.
Scientific Quality and Approach
Clear overall scientific strategy, methodology, and analyses to accomplish the specific aims must be stated in the application. If potential problems, alternative strategies, and benchmarks for success are available, it has to be presented.
Details of how the scientific environment in which the work is done will contribute to the probability of project success, must be stated. Examples include institutional support, equipment and availability of other physical resources. Project would be at an advantage if it states the benefit of unique features of the scientific environment, subject populations, or collaborative arrangements.
What this grant call will not fund:
• Solely clinical studies (e.g. Intervention studies, clinical trials, health care delivery research, particular medical interventions)
• Metabolism and Obesity related educational campaigns (E.g. Increasing obesity awareness amongst people)
• Screening (or similar) programmes or services / Health checks
• Programmes to implement new policies
• Activities / research that is solely based on data collection and investigating trends in Metabolism and Obesity (unless this is part of the research project that includes laboratory or clinical research conducted)
• Projects leading to duplication of resources, or developing resources which do not meet a need
Please refer to the guidelines for more information.
1. Online application - Internal Deadline: Thursday, 25 Apr 2013 (5pm, Singapore Standard Time)
- Kindly ensure that all tabs in the online forms are filled up completely. NUHS RO/ODPRT will check the submission before endorsing. Should amendments be required, the submission will be "rejected" back to the submitter for amendments and re-submission.
- Details such as word limitations and other requirements are stated in iGrants. No proposal templates are provided as PIs are advised to log into iGrants to get familiarized with the system. PIs can save their proposals as drafts before actual submission.
- Grant applications must be made through A*STAR and MOST.
- Singapore applicants are required to apply electronically via the iGrants system. All Co-PIs and Collaborators (from NUS or outside of NUS) are required to have an iGrants account.
- China applicants are required to submit their application forms to MOST, which can be found on the following websites: http://www.most.gov.cn and http://www.cistc.gov.cn .
2. Please forward the following documents to NUHS Research Office - Internal Deadline: Thursday, 25 Apr 2013
If the proposed study requires biospecimen or tissue banking, please contact Dr Eng Chon Boon (firstname.lastname@example.org ) from the NUHS Tissue Repository. The tissue repository will assist with the biobanking budgetary. Kindly visit http://medicine.nus.edu.sg/tissue/Cost%20Recovery%20Schedule.pdf.
Please contact the following staff if you have any enquiries: